Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis
RCS Seet, Y Zhang, EF Wijdicks… - Archives of …, 2011 - jamanetwork.com
Background It is unclear whether stroke patients with atrial fibrillation (AF) are prone to
adverse outcomes following treatment with intravenous recombinant tissue plasminogen …
adverse outcomes following treatment with intravenous recombinant tissue plasminogen …
Clinical and MRI predictors of no early recanalization within 1 hour after tissue-type plasminogen activator administration
K Kimura, Y Sakamoto, J Aoki, Y Iguchi, K Shibazaki… - Stroke, 2011 - Am Heart Assoc
Background and Purpose—The aim of the present study was to investigate independent
clinical and MRI factors associated with no early recanalization within 1 hour after tissue …
clinical and MRI factors associated with no early recanalization within 1 hour after tissue …
Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke
C Blinzler, L Breuer, HB Huttner… - Cerebrovascular …, 2011 - karger.com
Background: Recombinant tissue plasminogen activator (rt-PA) is the only approved specific
therapy for acute ischemic stroke. This study analyzes demographic and clinical …
therapy for acute ischemic stroke. This study analyzes demographic and clinical …
Admission hyperglycemia and serial infarct volume after t-PA therapy in patients with and without early recanalization
K Kimura, Y Sakamoto, Y Iguchi, K Shibazaki… - Journal of the …, 2011 - Elsevier
Background and purpose The present study examined the effects of admission
hyperglycemia and early recanalization (ER) after t-PA administration on infarct volume and …
hyperglycemia and early recanalization (ER) after t-PA administration on infarct volume and …
影响脑梗死静脉溶栓预后的相关因素分析
张春阳 - 中国实用神经疾病杂志, 2011 - cqvip.com
目的探讨可能影响脑梗死患者静脉溶栓预后的因素. 方法69 例急性脑梗死患者给予阿替普酶(
recombinant tissue plasminogen activator, rt—PA) 治疗, 以90d 时改良Rankin 量表(mRS) …
recombinant tissue plasminogen activator, rt—PA) 治疗, 以90d 时改良Rankin 量表(mRS) …
Serial changes in ischemic lesion volume and neurological recovery after t-PA therapy
K Kimura, Y Sakamoto, Y Iguchi, K Shibazaki - Journal of the neurological …, 2011 - Elsevier
BACKGROUND AND PURPOSE: The present study investigated the relationship between
serial changes in ischemic lesion volume (ILV) and neurological recovery after t-PA therapy …
serial changes in ischemic lesion volume (ILV) and neurological recovery after t-PA therapy …
[PDF][PDF] Atrial fibrillation and possibilities of stroke prevention
M Žikić, O Novosel, T Rabi Žikić, M Žarkov - Acta clinica Croatica, 2011 - hrcak.srce.hr
The morbidity and mortality associated with atrial fibrillation (AF) are related mainly to
ischaemic stroke, and the prevention of thrombo-embolism is an important component of the …
ischaemic stroke, and the prevention of thrombo-embolism is an important component of the …